Impact of aging on treatment considerations for multiple sclerosis patients

With a rapidly aging global population and improvement of outcomes with newer multiple sclerosis (MS)-specific disease-modifying therapies (DMTs), the epidemiology of MS has shifted to an older than previously described population, with a peak prevalence of the disease seen in the 55–65 years age gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Macaron, Gabrielle, Larochelle, Catherine, Arbour, Nathalie, Galmard, Manon, Girard, Jean Marc, Prat, Alexandre, Duquette, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361071/
https://www.ncbi.nlm.nih.gov/pubmed/37483447
http://dx.doi.org/10.3389/fneur.2023.1197212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361071/
https://www.ncbi.nlm.nih.gov/pubmed/37483447
http://dx.doi.org/10.3389/fneur.2023.1197212

Ejemplares similares